The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients
Clinical trial NCT06496009 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06496009
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-08
- Primary completion
- 2026-04-28
- Enrollment
- 845
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.